Navigation Links
23andMe acquires CureTogether, Inc.
Date:7/10/2012

Mountain View, CA July 10, 2012 23andMe, a leading personal genetics company, today announced its first acquisition with the purchase of CureTogether, Inc. The addition of CureTogether provides technology and talent that will improve 23andMe's ability to gather data for research while also providing customers with engaging and meaningful interactions in 23andMe's online community. Specific terms of the transaction were not disclosed.

"A driving force for the acquisition is the alignment of core values we share with CureTogether," 23andMe CEO and Co-Founder Anne Wojcicki. "It underscores 23andMe's commitment to helping individuals understand their own genetic information through proven DNA analysis technologies and web-based interactive tools; and generating patient-driven, informed-consent research as well as empowering our customers to use their personal genetic information to find connections and establish communities based on their DNA."

23andMe's Personal Genome Service enables individuals to explore their own DNA and currently provides more than 200 health and traits reports as well as genetic ancestry information. 23andMe's customer communities currently cover a wide range of topics from Relative Finder matches provided through the company's ancestry analysis, to disease-specific research communities such as Parkinson's Disease, Sarcoma, Myleoproliferative Neoplasms and the Roots Into The Future research community for African-Americans.

CureTogether brings to 23andMe additional tools and systems for gathering data from health-based communities that are complementary to the existing 23andMe platforms, allowing customers to share quantitative information on more than 500 medical conditions, talk about sensitive symptoms and compare which treatments work best for them as they track their health. CureTogether's platform includes more than 4 million phenotypic data points across those different health conditions that could help inform future genetic discoveries. "There are tremendous opportunities for our members and for future research by integrating the 23andMe and the CureTogether platforms and phenotypic data," explained CureTogether Co-Founder Daniel Reda, who joins 23andMe as senior product manager.

CureTogether was launched in 2008 initially to help people who live in daily chronic pain. Starting with three conditions, it quickly expanded as people wrote in to request that their conditions be added to their ongoing study. CureTogether, like 23andMe, is supported by social web-based platforms and is committed to patient-driven research, having partnered with researchers at leading universities and research institutions including Carnegie Mellon University, Cornell University, Drexel University, MIT Media Laboratory and Stanford University.

"We encourage our CureTogether members to join us in the 23andMe community," added CureTogether Co-Founder Alexandra Carmichael who joins 23andMe as senior product manager, "to help accelerate research discoveries enabled by this unprecedented compilation of community-contributed genetic and phenotypic data."

An ongoing service, 23andMe's Personal Genome Service provides a wealth of information about an individual's DNA and updates about new research. Customers can also choose to participate in the company's unique research programs. By completing online surveys, customers contribute directly to genetic research that can potentially lead to better understanding of and new treatments for a variety of health conditions. To learn more, visit www.23andme.com.


'/>"/>
Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
23andMe Inc.
Source:Eurekalert  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
23andMe acquires CureTogether, Inc.
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian ... Medical doctors and PhD scientists will speak to the press on behalf of over ... of an independent vaccine safety commission. , WHERE: , Zenger Room, National Press ...
(Date:3/28/2017)... ... 2017 , ... Calibration, qualification, and the appropriate level of ... GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled “ ... requirements are explained. The challenge is to determine how to put the ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... ... March 28, 2017 , ... In its ... Success website has recently developed and published an informational resource that addresses frequently ... based on common inquiries the site’s team of third party administrator (TPA) contributors ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally ... the “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists ... be aware of when utilizing dental laboratories and technicians that create these veneers. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 FinancialBuzz.com News Commentary  ... According to a new report by ... America , grew 34 percent to $6.7 billion and can be ... (CAGR) over the next five years, from $6.7 billion in 2016, to ... that will be able to purchase cannabis without a doctor,s recommendation. Voters ...
(Date:3/27/2017)... /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or ... is pleased to announce it has received conditional approval ... TSX Venture Exchange.  Receiving the conditional ... significant achievements for Invictus-MD. Some of which include: ... Laboratories Inc. ("AB Labs"), a Licensed Producer under the ...
(Date:3/27/2017)... Calif. , March 27, 2017 The ... in the wealthiest countries have access to the latest ... countries like the US, many patients have inadequate or ... debts or skip therapy altogether. Access to modern cancer ... less affluent countries. The mission statements ...
Breaking Medicine Technology: